# Genes in Predicting Outcome in Patients With Esophageal Cancer Treated With Cisplatin, Radiation Therapy, and Surgery

> **NCT00898495** · — · COMPLETED · sponsor: **ECOG-ACRIN Cancer Research Group** · enrollment: 118 (actual)

## Conditions studied

- Esophageal Cancer

## Interventions

- **GENETIC:** loss of heterozygosity analysis
- **GENETIC:** polymerase chain reaction
- **GENETIC:** polymorphism analysis

## Key facts

- **NCT ID:** NCT00898495
- **Lead sponsor:** ECOG-ACRIN Cancer Research Group
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05-11
- **Primary completion:** 2008-12-31
- **Final completion:** 2008-12-31
- **Target enrollment:** 118 (ACTUAL)
- **Last updated:** 2020-07-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00898495

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00898495, "Genes in Predicting Outcome in Patients With Esophageal Cancer Treated With Cisplatin, Radiation Therapy, and Surgery". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00898495. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*